CIPK29 Antibody

Shipped with Ice Packs
In Stock

Description

Novel or Emerging Target

  • CIPK29 could be a recently identified protein target undergoing preliminary characterization. Antibody development typically follows a multi-phase process:

    • Antigen identification (e.g., kinase domains, signaling proteins)

    • Hybridoma generation or recombinant antibody production

    • Validation through ELISA, Western Blot, and immunohistochemistry

Nomenclature Ambiguity

  • The designation "CIPK29" might correspond to:

    • A CBL-interacting protein kinase (common in plant biology, though not addressed in the provided clinical/therapeutic antibody sources)

    • A proprietary/internal identifier for a developmental therapeutic antibody (e.g., oncology or autoimmune targets)

Research Stage

  • Antibodies in preclinical development often lack publicly available data until they reach clinical trials. Key stages include:

Development PhaseTypical ActivitiesRelevant Initiatives
PreclinicalTarget validation, epitope mapping, in vitro efficacy testingNeuroMab, PCRP
Clinical TrialsSafety profiling, dose optimizationAntibody Characterization Laboratory
Regulatory ApprovalFDA/EMA review, manufacturing standardizationCPTAC, Affinomics

Key Challenges in Antibody Development (Relevant to CIPK29 Context)

  1. Characterization Crisis:

    • ~50–75% of commercial antibodies fail validation in common assays like Western Blot or immunofluorescence .

    • Recombinant antibodies show superior performance compared to traditional monoclonals .

  2. Therapeutic Hurdles:

    • Fc engineering requirements (e.g., effector function modulation)

    • Species cross-reactivity for translational studies

To advance understanding of CIPK29 Antibody, researchers should:

  • Consult specialized antibody repositories (e.g., Developmental Studies Hybridoma Bank )

  • Validate target specificity using knockout cell lines

  • Explore partnerships with antibody characterization consortia (e.g., YCharOS )

Product Specs

Buffer
Preservative: 0.03% Proclin 300
Constituents: 50% Glycerol, 0.01M Phosphate Buffered Saline (PBS), pH 7.4
Form
Liquid
Lead Time
Made-to-order (14-16 weeks)
Synonyms
CIPK29 antibody; Os07g0678300 antibody; LOC_Os07g48090 antibody; OJ1409_C08.10 antibody; OsJ_024572CBL-interacting protein kinase 29 antibody; EC 2.7.11.1 antibody; OsCIPK29 antibody
Target Names
CIPK29
Uniprot No.

Target Background

Function
CIPK serine-threonine protein kinases engage in interactions with CBL proteins. The binding of a CBL protein to the regulatory NAF domain of a CIPK protein results in the activation of the kinase in a calcium-dependent manner.
Database Links
Protein Families
Protein kinase superfamily, CAMK Ser/Thr protein kinase family, SNF1 subfamily

Q&A

What is CIPK29 and what is its significance in plant research?

CIPK29 is a member of the CIPK (CBL-Interacting Protein Kinase) family, which functions in stress response signaling pathways in plants. Based on research with related CIPK genes, CIPK29 likely interacts with calcium sensor CBL proteins to transduce stress signals and regulate downstream responses. The CIPK gene family has been extensively studied in rice, with 30 identified members (OsCIPK01-OsCIPK30) . CIPK proteins are particularly significant for understanding plant responses to abiotic stressors including drought, salinity, and cold. Studies have demonstrated that certain CIPK genes, when overexpressed, can significantly improve plant tolerance to specific environmental stresses .

How are CIPK29 antibodies used in molecular and cellular research?

CIPK29 antibodies serve as essential tools for investigating the expression, localization, and function of CIPK29 proteins. The primary applications include:

  • Western blotting to detect and quantify CIPK29 protein expression

  • Immunoprecipitation to study protein-protein interactions

  • Immunofluorescence microscopy to examine subcellular localization

  • Chromatin immunoprecipitation to identify DNA-binding sites

  • Flow cytometry to analyze protein expression in different cell populations

Similar to research methodologies used with other proteins in the CIPK family, these techniques allow researchers to investigate the phosphorylation status and functional roles of CIPK29 in stress-responsive signaling cascades .

What are the recommended protocols for validating CIPK29 antibody specificity?

For rigorous CIPK29 antibody validation, researchers should implement multiple complementary approaches:

  • Western blot analysis with positive and negative controls:

    • Use tissue/cells known to express CIPK29 as positive controls

    • Use CIPK29 knockout or knockdown samples as negative controls

    • Run parallel blots with pre-immune serum to verify specificity

  • Peptide competition assay:

    • Pre-incubate the antibody with the immunizing peptide

    • Compare immunostaining with and without peptide competition

    • Specific binding should be blocked by the cognate peptide

  • Cross-reactivity assessment:

    • Test against recombinant proteins of closely related CIPK family members

    • Particularly important given the high sequence homology between CIPK proteins

    • Document cross-reactivity with other CIPK proteins for accurate data interpretation

  • Immunoprecipitation followed by mass spectrometry:

    • Verify that the immunoprecipitated protein is indeed CIPK29

    • Identify potential cross-reactive proteins

These validation steps are crucial since antibody specificity directly impacts experimental outcomes and reproducibility of research findings .

What are the optimal conditions for detecting CIPK29 phosphorylation status?

Based on research with related proteins like Cip29, which undergoes stress-induced phosphorylation, the following methodological approach is recommended:

  • Sample preparation:

    • Rapidly harvest and flash-freeze tissue to preserve phosphorylation state

    • Include phosphatase inhibitors in all extraction buffers

    • Consider subcellular fractionation to enrich for compartments where CIPK29 functions

  • Detection methods:

    • Phos-tag SDS-PAGE to separate phosphorylated from non-phosphorylated forms

    • Phospho-specific antibodies if available for specific phosphorylation sites

    • Mass spectrometry for phosphosite mapping and quantification

  • Stress induction protocols:

    • Apply relevant stressors (drought, salinity, cold) with appropriate timing

    • Include positive controls using known activators of the CIPK pathway

    • Consider time-course experiments to capture transient phosphorylation events

  • Kinase activity assays:

    • In vitro kinase assays with immunoprecipitated CIPK29

    • Monitor autophosphorylation and substrate phosphorylation

The DNA damage-responsive phosphorylation of related proteins like Cip29 suggests that careful experimental design is necessary to capture stress-specific modifications of CIPK29 .

How should researchers optimize immunohistochemistry protocols for CIPK29 detection in plant tissues?

For effective immunohistochemical detection of CIPK29 in plant tissues:

  • Fixation optimization:

    • Test multiple fixatives (4% paraformaldehyde, Carnoy's solution)

    • Adjust fixation time to balance antigen preservation and tissue penetration

    • Consider antigen retrieval methods if necessary

  • Blocking and antibody incubation:

    • Use 3-5% BSA or normal serum from the species of secondary antibody

    • Optimize primary antibody dilution (typically 1:100 to 1:1000)

    • Consider extended incubation at 4°C (overnight to 48 hours)

  • Signal enhancement and background reduction:

    • Use tyramide signal amplification for low-abundance proteins

    • Include detergents (0.1-0.3% Triton X-100) to improve antibody penetration

    • Include multiple washing steps with PBS-T

  • Controls and validation:

    • Include tissue from CIPK29 knockout/knockdown plants

    • Perform peptide competition controls

    • Use fluorescent secondaries with non-overlapping spectra for co-localization studies

  • Tissue-specific considerations:

    • Modify protocols based on tissue type (roots, leaves, reproductive structures)

    • Consider tissue clearing techniques for deeper imaging

    • Adapt sectioning thickness based on tissue density

These methodological details are critical for reliable spatial analysis of CIPK29 expression patterns across different plant tissues and stress conditions.

How can CIPK29 antibodies be employed to investigate protein-protein interactions in stress signaling networks?

Advanced researchers can leverage CIPK29 antibodies to dissect complex signaling networks through:

  • Co-immunoprecipitation (Co-IP) strategies:

    • Use CIPK29 antibodies conjugated to magnetic or agarose beads

    • Perform reciprocal Co-IPs to confirm interactions

    • Consider crosslinking approaches for transient interactions

    • Extract proteins under native conditions to preserve complexes

  • Proximity-dependent labeling:

    • Generate fusion constructs of CIPK29 with BioID or APEX2

    • Use antibodies to validate expression of fusion proteins

    • Identify proximal proteins through mass spectrometry

  • Fluorescence microscopy techniques:

    • Förster Resonance Energy Transfer (FRET) to detect direct interactions

    • Bimolecular Fluorescence Complementation (BiFC) for in vivo interaction verification

    • Co-localization studies using CIPK29 antibodies with antibodies against potential interactors

  • Dynamic interaction analysis:

    • Time-course experiments following stress application

    • Compare interaction profiles under different stress conditions

    • Quantify changes in interaction strength and composition

Understanding protein-protein interactions is particularly important for CIPK family members, as they function through interactions with calcium sensors (CBLs) and various downstream targets in stress response pathways .

What are the considerations for using CIPK29 antibodies in chromatin immunoprecipitation sequencing (ChIP-seq) studies?

While CIPK proteins are primarily cytoplasmic kinases, some research indicates nuclear localization under specific conditions. For researchers investigating potential chromatin-associated functions:

  • ChIP protocol optimization:

    • Crosslinking conditions: test different formaldehyde concentrations (0.75-1.5%) and incubation times

    • Sonication parameters: optimize to generate 200-500 bp fragments

    • Antibody selection: use ChIP-grade antibodies validated for this application

    • Include appropriate controls (IgG, input DNA)

  • Data analysis considerations:

    • Use stringent peak-calling parameters to minimize false positives

    • Validate peaks with ChIP-qPCR

    • Perform motif enrichment analysis

    • Compare binding patterns under different stress conditions

  • Integration with other data types:

    • Correlate with RNA-seq to identify direct regulatory targets

    • Integrate with protein-protein interaction data

    • Compare with epigenetic modification profiles

  • Technical challenges and solutions:

    • Low signal-to-noise ratio: consider sequential ChIP or CUT&RUN alternatives

    • Cross-reactivity: validate with CIPK29 knockout/knockdown controls

    • Spatial resolution: consider using high-resolution techniques like ChIP-exo

This approach would be particularly valuable for investigating whether CIPK29 directly or indirectly influences gene expression during stress responses, similar to how some stress-responsive factors function .

How can phospho-specific antibodies against CIPK29 be used to map stress signaling dynamics?

Developing and utilizing phospho-specific antibodies against CIPK29 would enable detailed mapping of signaling cascades:

  • Identification of key phosphorylation sites:

    • Perform mass spectrometry analysis of CIPK29 under various stress conditions

    • Generate phospho-specific antibodies against the identified sites

    • Validate antibody specificity using phosphatase-treated samples and phospho-mimetic mutants

  • Temporal phosphorylation dynamics:

    • Conduct time-course experiments following stress application

    • Track specific phosphorylation events with phospho-antibodies

    • Correlate phosphorylation patterns with physiological responses

  • Spatial phosphorylation patterns:

    • Use immunohistochemistry with phospho-specific antibodies

    • Map tissue-specific and subcellular phosphorylation events

    • Track movement of phosphorylated CIPK29 between cellular compartments

  • Quantitative analysis:

    • Western blotting with phospho-specific and total CIPK29 antibodies

    • Calculate phosphorylation ratios under different conditions

    • Develop mathematical models of phosphorylation dynamics

This approach parallels studies of other stress-responsive proteins like Cip29, which undergoes ATM-dependent phosphorylation following DNA damage .

What are the common pitfalls in experimental design when using CIPK29 antibodies and how can they be avoided?

Researchers should be aware of several critical considerations when designing experiments with CIPK29 antibodies:

  • Antibody validation concerns:

    • Pitfall: Assuming antibody specificity without proper validation

    • Solution: Perform comprehensive validation using knockout/knockdown controls, Western blotting, peptide competition, and immunoprecipitation followed by mass spectrometry

  • Sample preparation issues:

    • Pitfall: Loss of phosphorylation status during extraction

    • Solution: Rapid harvesting, flash-freezing, and inclusion of phosphatase inhibitors

  • Cross-reactivity with other CIPK family members:

    • Pitfall: Misattribution of signals due to antibody cross-reactivity

    • Solution: Test antibody against recombinant proteins of all close family members; consider using genetic approaches (CRISPR, RNAi) to confirm observations

  • Stress application standardization:

    • Pitfall: Inconsistent stress application leading to variable results

    • Solution: Develop standardized protocols for stress treatment timing, intensity, and duration

  • Control selection:

    • Pitfall: Inadequate experimental controls

    • Solution: Include negative controls (pre-immune serum, IgG), positive controls, and experimental controls (multiple CIPK family members)

Addressing these common pitfalls proactively ensures more reliable and reproducible research outcomes.

How can researchers interpret contradictory results when studying CIPK29 expression across different plant tissues and stress conditions?

When faced with contradictory results in CIPK29 expression studies:

  • Methodological reconciliation:

    • Compare detection methods (Western blot, qPCR, immunohistochemistry)

    • Assess antibody specificity in each tissue type

    • Consider the sensitivity limits of each technique

  • Biological variability factors:

    • Evaluate developmental stage differences

    • Assess environmental condition variations

    • Consider genetic background effects

    • Examine tissue-specific post-translational modifications

  • Temporal dynamics:

    • Compare sampling timepoints after stress application

    • Consider the possibility of biphasic or oscillating responses

    • Evaluate long-term versus short-term stress responses

  • Stress intensity assessment:

    • Quantify the applied stress (e.g., water potential, salt concentration)

    • Consider hormetic effects (different responses at different stress intensities)

    • Evaluate combinatorial stress effects

  • Contextual data analysis:

    • Triangulate results with other family members' expression

    • Consider the environmental niche of the study species

    • Compare with evolutionary related species

This analytical approach aligns with observations that CIPK family members show complex, stress-specific expression patterns, with some genes responding primarily to single stressors while others respond to multiple stress conditions .

How does CIPK29 antibody-based research compare with genetic approaches for studying CIPK29 function?

Antibody-based approaches and genetic techniques offer complementary advantages and limitations:

ApproachAdvantagesLimitationsComplementary Uses
Antibody-based methods- Detect endogenous protein
- Reveal post-translational modifications
- Allow subcellular localization studies
- Capture protein-protein interactions
- Can be used across species with conserved epitopes
- Potential cross-reactivity
- Limited temporal control
- Varying accessibility in tissues
- Batch-to-batch variability
- May not distinguish splice variants
- Validate genetic modification effects at protein level
- Study post-translational regulation
- Examine protein complex formation
Genetic approaches- Precise gene targeting
- Clear phenotypic outcomes
- Temporal control (inducible systems)
- Tissue-specific manipulation
- Study of specific domains/residues
- Potential off-target effects
- Compensation by homologous genes
- May affect development
- Cannot directly study PTMs
- Labor-intensive
- Generate controls for antibody validation
- Confirm antibody-derived observations
- Create systems for structure-function studies

Integrating both approaches provides the most comprehensive understanding of CIPK29 function, similar to studies with other CIPK family members that combined overexpression studies with protein-level analyses to elucidate stress response mechanisms .

What patterns of CIPK gene expression have been observed under different stress conditions?

Based on the research with rice CIPK genes, the following expression patterns have been observed:

CIPK GeneDroughtSaltColdPEGABA TreatmentKey Findings
OsCIPK01InducedInducedInducedInducedInducedResponds to multiple stresses
OsCIPK03Not inducedNot inducedStrongly inducedSlightly inducedSlightly inducedCold-specific response
OsCIPK09InducedInducedInducedInducedInducedMulti-stress responsive
OsCIPK12InducedInducedNot reportedInducedInducedImproves drought tolerance when overexpressed
OsCIPK15InducedInducedNot reportedInducedInducedImproves salt tolerance when overexpressed
Other CIPKsVariable response patternsVariable response patternsGenerally fewer cold-responsive CIPKsSimilar to drought patternsMost drought-induced CIPKs also ABA-induced20 of 30 OsCIPK genes responsive to at least one stress

This expression pattern data suggests that while CIPK29 has not been specifically characterized in these studies, it likely follows one of these response patterns based on its membership in the CIPK family. Researchers should design experiments to determine whether CIPK29 is a multi-stress responsive gene or shows stress specificity .

How can CIPK29 antibodies be used to investigate potential roles in DNA damage response pathways?

While CIPK proteins are primarily studied in the context of abiotic stress responses, research on related proteins like Cip29 suggests potential roles in DNA damage response:

  • Phosphorylation analysis after DNA damage:

    • Treat plants with DNA-damaging agents (UV, radiomimetic drugs)

    • Use CIPK29 antibodies to immunoprecipitate the protein

    • Perform phospho-mapping by mass spectrometry

    • Compare with known phosphorylation patterns under abiotic stress

  • ATM/ATR kinase dependency testing:

    • Use ATM/ATR inhibitors or mutant plants

    • Assess CIPK29 phosphorylation status using phospho-specific antibodies

    • Determine if CIPK29 is a direct or indirect target of DNA damage response kinases

  • Nuclear localization studies:

    • Examine CIPK29 subcellular distribution before and after DNA damage

    • Use immunofluorescence microscopy with nuclear markers

    • Investigate potential nuclear-cytoplasmic shuttling

  • Protein-protein interaction network:

    • Perform co-immunoprecipitation with CIPK29 antibodies after DNA damage

    • Identify interacting partners by mass spectrometry

    • Compare with interaction networks under other stress conditions

This research direction is supported by findings that Cip29, a putative RNA export factor, undergoes rapid ATM-dependent phosphorylation following DNA double-strand breaks, suggesting interconnections between different stress response pathways .

What are the most effective troubleshooting strategies for inconsistent CIPK29 antibody performance?

When encountering variability in CIPK29 antibody performance, implement this systematic troubleshooting approach:

  • Storage and handling assessment:

    • Check antibody storage conditions (temperature, freeze-thaw cycles)

    • Examine buffer composition and pH

    • Consider adding stabilizers (glycerol, BSA) if not present

    • Prepare fresh working dilutions from concentrated stock

  • Sample preparation evaluation:

    • Optimize extraction buffers for different tissue types

    • Test multiple lysis conditions (detergent types/concentrations)

    • Consider native vs. denaturing conditions based on application

    • Evaluate the effect of phosphatase inhibitors on signal detection

  • Protocol optimization:

    • Systematically vary antibody concentration, incubation time, and temperature

    • Test different blocking agents (milk, BSA, normal serum)

    • Modify washing stringency and duration

    • Consider signal enhancement methods for low-abundance proteins

  • Antibody validation:

    • Perform epitope mapping to identify the exact recognition site

    • Test antibody against recombinant CIPK29 protein

    • Evaluate batch-to-batch variation with standardized positive controls

    • Consider purifying the antibody if necessary

  • Application-specific troubleshooting:

    • For Western blotting: optimize transfer conditions and membrane type

    • For immunoprecipitation: adjust bead type and binding conditions

    • For immunohistochemistry: test different fixation and antigen retrieval methods

These approaches parallel troubleshooting strategies used in studies of other plant stress response proteins and kinases .

How can researchers determine if changes in CIPK29 detection are due to actual biological variation or technical artifacts?

To distinguish between true biological changes and technical artifacts:

  • Implement comprehensive controls:

    • Include loading controls (housekeeping proteins) for Western blots

    • Use recombinant CIPK29 protein as a positive control

    • Process all experimental samples simultaneously when possible

    • Include technical replicates to assess method variability

  • Employ multiple detection methods:

    • Verify protein-level changes with transcript-level measurements

    • Use different antibodies targeting distinct epitopes if available

    • Complement antibody detection with tagged versions of the protein

    • Apply orthogonal techniques (e.g., mass spectrometry) for verification

  • Conduct quantitative analysis:

    • Use image analysis software for densitometry

    • Calculate coefficients of variation for technical replicates

    • Perform appropriate statistical tests with biological replicates

    • Consider Bayesian approaches for separating signal from noise

  • Validate with genetic approaches:

    • Compare results with CIPK29 overexpression lines

    • Assess detection in knockout/knockdown lines as negative controls

    • Consider dose-response experiments with varying expression levels

  • Standardize experimental conditions:

    • Maintain consistent growth conditions for plant material

    • Standardize stress application protocols

    • Document all variables that could affect CIPK29 expression or modification

This framework for distinguishing biological variation from technical artifacts is essential for generating reliable data on stress-responsive proteins like those in the CIPK family .

Quick Inquiry

Personal Email Detected
Please use an institutional or corporate email address for inquiries. Personal email accounts ( such as Gmail, Yahoo, and Outlook) are not accepted. *
© Copyright 2025 TheBiotek. All Rights Reserved.